Description
A c-Fms kinase inhibitor (IC50 = 2 nM); inhibits CSF1-dependent c-Fms phosphorylation in a dose-dependent manner in RAW264.7 cells; reduces CSF1-dependent growth of M-NFS-60 cells (IC50 = 14 nM); suppresses development of TRAP-positive osteoclast-like cells from murine bone marrow (IC50 = 40 nM); decreases the number and area of osteolytic lesions on femurs and tibiae in a murine A375 subcutaneous xenograft model; reduces TNF-α infiltration and osteolytic bone destruction in a CIA mouse model,
Formal name: N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N’-[1-(2-thiazolyl)ethyl]-urea
Synonyms:
Molecular weight: 480.5
CAS: 623142-96-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Receptor Tyrosine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer